Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children
ContributorsMahler, V; Mentzer, D; Bonertz, A; Muraro, A; Eigenmann, Philippe
; Bousquet, J; Halken, S; Pfaar, O; Jutel, M; Wahn, U; Vieths, S; Kaul, S
Published inClinical and Translational Allergy, vol. 10, 28
Publication date2020
Abstract
Keywords
- Allergen Immunotherapy (AIT)
- Children
- Paediatric Investigation Plan (PIP)
- Therapy Allergen Ordinance
- (TAO)
- Paediatric Committee (PDCO)
- European Medicines Agency (EMA)
Affiliation entities
Research groups
Citation (ISO format)
MAHLER, V et al. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children. In: Clinical and Translational Allergy, 2020, vol. 10, p. 28. doi: 10.1186/s13601-020-00327-w
Main files (1)
Article (Published version)
Identifiers
- PID : unige:142703
- DOI : 10.1186/s13601-020-00327-w
- PMID : 32612805
Additional URL for this publicationhttps://ctajournal.biomedcentral.com/articles/10.1186/s13601-020-00327-w
Journal ISSN2045-7022